Canaccord analyst T. Michael Walkley noted Impinj reported solid Q3 results with revenues slightly above guidance and returning to year-over-year growth for the first time since Q3 2017. The analyst believes the industry will return to more normalized growth and with the company's relationships with leading retailers and healthcare providers, it is in a solid position to increase market penetration. Walkley reiterated his Buy rating and $31 price target on Impinj shares.

Lake Street raised the firm's price target on Impinj to $155 from $118 and keeps a Buy rating on the shares after the company reported better than expected revenue, AEBITDA, and EPS results as momentum experienced in Q4 continued in Q1. While "the big headline guidance stands out the most, we think investors should not lose sight of the strong upside results and the fact guidance was still above estimates when excluding the license payment," says the analyst, who continues to think Impinj is positioned to drive meaningful top and bottom line growth this year and next.

Roth MKM analyst Scott Searle raised the firm's price target on Impinj to $145 from $125 and keeps a Buy rating on the shares after its Q1 earnings beat. The ongoing adoption of RFID continues with key 2024 customer deployments on track, the analyst tells investors in a research note. The firm is also raising its estimates on the stock due in part to endpoint IC recovery and market growth, though it also expects the early aftermarket stock pop to wane upon digestion of the upside contribution, Roth MKM added.

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj (PI) to $150 from $140 and keeps a Positive rating on the shares. The firm said they posted a solid print with additional upside driven by the licensing win from NXP Semiconductors (NXPI). Customer engagements and new RFID markets continue to broaden the opportunity.

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj to $140 from $130 and keeps a Positive rating on the shares. The firm previewed their semiconductors space for Q1 and raised its target onselect names despite expecting broad-based headwinds although admitting different markets/companies remain at different sections of the downcycle.